Rakovina Therapeutics appoints Yale brain-tumor researcher to scientific advisory board

Sep 17, 2026 08:30 (36d ago)

Verifying

Rakovina Therapeutics appointed Dr. Ranjit Bindra to its Scientific Advisory Board.
The company received a gross SR&ED refund of $920,846.10 including interest.
Rakovina granted 2,910,500 options exercisable at $0.20 per common share.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.